Evidence map›Paper›PMID 32870379›Full record

ArticleEuropean journal of clinical pharmacology2021

Iron chelation may harm patients with COVID-19.

Michael D Garrick, Andrew J Ghio

Erratum issuedAbstract readLetterComment
In one paragraph

Article in European journal of clinical pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The role of cell death in SARS-CoV-2 infection.Signal transduction and targeted therapy · 2023
    Review
  3. Article
  4. Review
  5. Review
  6. Multifaceted Roles of Ferroptosis in Lung Diseases.Frontiers in molecular biosciences · 2022
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Reply: Iron chelation may harm patients with COVID-19.European journal of clinical pharmacology · 2021
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Michael D GarrickDepartment of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA. mgarrick@buffalo.edu.ORCID https://orcid.org/0000-0001-7342-6983
Andrew J GhioUS Environmental Protection Agency, Chapel Hill, NC, USA.

Funding

Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-DeficiencyR01DK074867 · NIDDK · UNIVERSITY OF FLORIDA · PI COLLINS, JAMES F., VIDYASAGAR, SADASIVAN · 2007 to 2022
$5.1M
Divalent Metal-ion Transporter 1 as a Therapeutic Target to Optimize Intestinal Iron TransportR01DK109717 · NIDDK · UNIVERSITY OF FLORIDA · PI COLLINS, JAMES F. · 2016 to 2020
$2.6M
NIDDK NIH HHS R01 DK074867NIDDK NIH HHS R01 DK109717NIH HHS R01DK109717
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansIron Chelating AgentsSARS-CoV-2Iron Chelating Agents

Identifiers

PMID32870379
PMCPMC7459091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.